Skip to main content
ELDN
NASDAQ Life Sciences

Eledon Posts $69.7M Cash, Runway to Q2 2027 as Q3 Loss Widens Ex-Warrant Gain

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2.41
Mkt Cap
$192.183M
52W Low
$1.35
52W High
$4.49
52W Position info
79% above low
Off High info
46% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

ELDN sits 79% above its 52-week low of $1.35.

Summary

Eledon ended September 30 with $69.7M in cash, equivalents and short-term investments, down from $133.3M at December 31, 2025, and says that funds operations into Q2 2027. The Q3 net loss of $3.9M is flattered by a $17.0M non-cash warrant-liability gain; excluding it, the loss was $21.0M versus $18.0M a year earlier, with R&D spending up to $17.8M from $15.0M. The cash burn against a roughly $192M market cap makes the runway the number that matters here — the company has to raise money or deliver a partnering deal before mid-2027. On the clinical side, Eledon plans to start its Phase 3 kidney trial in Q4 2026, has FDA clearance for an islet-transplantation IND in type 1 diabetes, and holds Fast Track status for kidney transplant. Watch for the Phase 3 trial start in Q4 2026 and any financing announcement, since the 10-Q carries an explicit going-concern warning that funding runs short within twelve months.

At the time of this announcement, ELDN was trading at $2.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $192.2M. The 52-week trading range was $1.35 to $4.49. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

ELDN - Latest Insights

ELDN
Nov 12, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.41
Real-time Price: $2.40 info
Change: -$0.0097 (-0.40%) info
Market Cap: $192.183M info
ELDN
Nov 12, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.41
Real-time Price: $2.40 info
Change: -$0.0097 (-0.40%) info
Market Cap: $192.183M info
ELDN
Oct 26, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.31
Real-time Price: $2.40 info
Change: +$0.0903 (+4%) info
Market Cap: $192.183M info
ELDN
Sep 22, 2026, 1:48 PM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $2.89
Real-time Price: $2.40 info
Change: -$0.4847 (-17%) info
Market Cap: $192.183M info
ELDN
Aug 13, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.61
Real-time Price: $2.40 info
Change: -$1.21 (-34%) info
Market Cap: $192.183M info